APAC Commercial GPCRs Industry Marketing Channels and Feasibility 2021

Press Release   •   May 25, 2016 17:40 EDT


The communication in the cell of any organism occurs in micro level in GPCRs, also known as g protein coupled receptors. The pharmaceutical companies want to target GPCR for synthesizing the effective drug for humans in upcoming years. Huge pharmaceutical companies invest high amount of capital in the research and development of the structure based drug discovery methodologies for the future.

The global and Chinese GPCRs Industry is dominated by the USA, which invests heavily in g protein drug discovery efforts. The companies from the North America expect to patent the successful drug or methodologies to achieve profit in the future. The competition is very high in the market and this competition among companies is the driving force of the market.

In APAC region, China is heavily investing in this biotechnology for advancement in the field for drug discovery in the global and Chinese GPCRs Industry. APAC is also the largest market region for the market. Germany, UK and Finland are the prominent regions that can be expected to have a breakthrough innovation in this market.

Check Complete Report @

Topics Covered in this report:

The global and Chinese GPCRs Industry can be segmented into various categories by application, by industry and by geography are as follows.

By application: screening, discovery and others

By end users: research institutes, hospitals, biological centers and so on

By geography: North America, South America, Europe, Asia Pacific and ROW

Some of the noteworthy companies in the global and Chinese GPCRs Industry are as follows:

The Global GPCRs Industry companies are:

  • PerkinElmer Life and Analytical Sciences
  • DiscoveRx
  • Euroscreen
  • Evotec
  • Bayer Schering Pharma

Download Sample Brochure @

The Chinese GPCRs Industry companies are:

  • Hangzhou Gmax Biopharm Biomedical Engineering Co. Ltd.
  • HD Biosciences
  • Bird Rock Bio formerly known as RuiYi Inc.

The global and Chinese GPCRs Industry is expected to witness a boom in upcoming years with the increasing interest in drug discovery techniques and heavy investment of various countries in this technology. Since, the GPCRs market is rapidly growing with intense research and experiment results, high range of profit is expected in this industry in upcoming years.

Order a copy of Global and Chinese GPCRs Industry, 2016 Market Research Report@

About us:

MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.

A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.

MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.

MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.

Contact Us:

Sales Manager


2711 Centerville Road, Suite 400,
United States
Email Id:
Telephone 1 : 1-302-684-6088